Cardio-CARE featured on Illumina

Can Genomics Stop the World’s Leading Cause of Death? Read the article on Illuminas website: Can Genomics Stop the World’s Leading Cause of Death? (

Kühne-Foundation Annual Report 2021

“The Kühne Foundation has dedicated itself to education and research as well as science in the field of logistics – including humanitarian logistics. Another focus is our medicine funding through research, therapy and training for allergology and gebirgsklinik, a renowed rehabilitation hospital, and various research institutions. In the area of culture, we support leading opera […]

Cardio-CARE featured in local newspaper

Are cardiac infarctions hereditary? Davos and Hamburg searching for disease genes. Two years ago, a study involving 9000 persons has been initiated in close collaboration between the Universitätsklinikum Hamburg-Eppendorf and Cardio-CARE in Davos. 8000 of these persons have been selected at random, 1000 persons were diagnosed with cardiovascular diseases. The goal of this project is to find mutations in the genome which lead to cardiovascular diseases.

Kühne-Foundation Annual Report 2020

Key priority of the Kühne Foundation is the support for training, further education as well as research and science in the area of logistics. This also includes Humanitarian Logistics and a project concentrating on free global trade.

A new patent submitted

Professor Andreas Ziegler, as the co-inventor, submitted the computing device for estimating the probability of myocardial infarction to European Patent Office. This work is in collaboration with the University Heart & Vascular Center Hamburg (UHZ).

Andreas Ziegler appointed as the scientific director and CEO of Cardio-CARE

On January 1, 2020, Prof. Dr. Andreas Ziegler started as scientific director and CEO of Cardio-CARE. He is a board-certified biostatistician and epidemiologist. His research activities include Genetic Epidemiology, clinical trials for medical devices and artificial intelligence. Detailed information could be found in his CV.